Lucid Diagnostics Inc. (LUCD) Reports In-Line Q3 EPS

Lucid Diagnostics Inc. (NASDAQ: LUCD) reported Q3 EPS of ($0.22), in-line with the analyst estimate of ($0.22). Revenue for the quarter came in at $800 thousand versus the consensus estimate of $792.69 thousand.

For earnings history and earnings-related data on Lucid Diagnostics Inc. (LUCD) click here.

You May Also Be Interested In

• Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
• Goldman Sachs Reiterates Buy Rating on Samsung Electronics Co Ltd. (005930:KS) (SSNLF)
• RBC Capital Starts Shawbrook Group plc (SHAW:LN) at Outperform